These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 364604)

  • 21. A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis.
    Rejholec V; Vapaatalo H; Tokola O; Gothoni G
    Scand J Rheumatol Suppl; 1979; (24):13-6. PubMed ID: 373084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [4-prenyl-1,2-diphenyl-3,5-pyrazolidindione (DA 2370) in rheumatoid arthritis: clinical study with the use of a new weighted articular index].
    Cerri B; Bianchi G; Chierichetti S
    Reumatismo; 1972; 24(3):217-24. PubMed ID: 4549698
    [No Abstract]   [Full Text] [Related]  

  • 23. [Report of a controlled clinical trial of a new synthetic drug, parsalmide, in rheumatic arthropathies (inflammatory and degenerative)].
    Sanguinetti CM; Bonifazi F
    Minerva Med; 1976 Oct; 67(52):3391-5. PubMed ID: 792738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Celecoxib: a COX-2 inhibitor.
    Andrews SA; Wallace CK; Davis RL
    Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical evaluation of proglumetacin malate in rheumatoid arthritis--a multi-institutional cooperative study].
    Ryumachi; 1986 Oct; 26(5):377-88. PubMed ID: 3299753
    [No Abstract]   [Full Text] [Related]  

  • 27. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
    Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
    [No Abstract]   [Full Text] [Related]  

  • 28. [Non-steroidal anti-inflammatory therapy in rheumatology].
    Sigidin IaA
    Ter Arkh; 1986; 58(7):3-8. PubMed ID: 3764738
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug therapy of pain in patients with rheumatoid arthritis].
    Pavelka K; Tellerová K; Trnavský K
    Cas Lek Cesk; 1984 Apr; 123(14):407-11. PubMed ID: 6143615
    [No Abstract]   [Full Text] [Related]  

  • 30. The systematic study of drug therapy in rheumatoid arthritis.
    Johnson K
    J Rheumatol Suppl; 1990 Nov; 25():34-8. PubMed ID: 2273520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The course of patients treated with placebo in trials of maintenance treatment of rheumatoid arthritis. Consequences for phase II studies].
    Méry C; George N; de Géry A; Job-Deslandre C; Menkès CJ; Amor B
    Rev Rhum Mal Osteoartic; 1990 Feb; 57(2):119-22. PubMed ID: 2181611
    [No Abstract]   [Full Text] [Related]  

  • 32. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 33. [Double-blind clinical trial of pirprofen in patients with rheumatoid arthritis].
    Shichikawa K; Nagaya I; Ogawa N
    Ryumachi; 1984 Oct; 24(5):407-14. PubMed ID: 6395372
    [No Abstract]   [Full Text] [Related]  

  • 34. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-steroidal anti-inflammatory drugs.
    Gøtzsche PC
    Clin Evid; 2002 Jun; (7):1063-70. PubMed ID: 12230727
    [No Abstract]   [Full Text] [Related]  

  • 36. [New basic preparations with prolonged action in the treatment of rheumatoid arthritis].
    Tumanova IG; Sigidin IaA
    Ter Arkh; 1987; 59(4):80-3. PubMed ID: 2884735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double blind comparison of tiaprofenic acid with placebo.
    Palmer M; Highton J; Palmer DG
    N Z Med J; 1988 May; 101(845):240-1. PubMed ID: 3285254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodology issues in the evaluation of NSAID in inflammatory rheumatic diseases.
    Lequesne M
    J Rheumatol Suppl; 1990 Feb; 20():25-8. PubMed ID: 2182853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
    MMW Fortschr Med; 2004 Mar; 146(13):61. PubMed ID: 15219139
    [No Abstract]   [Full Text] [Related]  

  • 40. ACR 20: clinical or statistical significance?
    Pincus T; Stein CM
    Arthritis Rheum; 1999 Aug; 42(8):1572-6. PubMed ID: 10446853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.